Inactive Instrument

Akers Biosciences, Inc. London S.E.

Equities

USU009441051

End-of-day quote London S.E. Other stock markets
- ^GBX	-

Akers Biosciences, Inc. : Interim Results for the Six Months Ended 30 June 2013

August 22, 2013 at 10:32 am EDT

MarketScreener.com By

Embargoed: 0700hrs, 22 August 2013

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION OR DISSEMINATION IN OR INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

Akers Biosciences, Inc.

("ABI" or the "Company")

Interim Results for the Six Months Ended 30 June 2013

ABI, a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce its interim results for the half year ended 30 June 2013.

Financial Highlights